ATE185567T1 - Cephalosporine und ihre homologen, zubereitungen und pharmazeutsiche präparate - Google Patents
Cephalosporine und ihre homologen, zubereitungen und pharmazeutsiche präparateInfo
- Publication number
- ATE185567T1 ATE185567T1 AT91913583T AT91913583T ATE185567T1 AT E185567 T1 ATE185567 T1 AT E185567T1 AT 91913583 T AT91913583 T AT 91913583T AT 91913583 T AT91913583 T AT 91913583T AT E185567 T1 ATE185567 T1 AT E185567T1
- Authority
- AT
- Austria
- Prior art keywords
- preparations
- cephalosporins
- homologues
- pharmaceutical
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909016189A GB9016189D0 (en) | 1990-07-24 | 1990-07-24 | Novel compounds |
| GB919109540A GB9109540D0 (en) | 1991-05-02 | 1991-05-02 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE185567T1 true ATE185567T1 (de) | 1999-10-15 |
Family
ID=26297372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91913583T ATE185567T1 (de) | 1990-07-24 | 1991-07-22 | Cephalosporine und ihre homologen, zubereitungen und pharmazeutsiche präparate |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP0540609B1 (de) |
| JP (2) | JP2851428B2 (de) |
| KR (1) | KR100189075B1 (de) |
| CN (2) | CN1061046C (de) |
| AP (1) | AP832A (de) |
| AT (1) | ATE185567T1 (de) |
| AU (1) | AU648329B2 (de) |
| CA (2) | CA2359744C (de) |
| CZ (1) | CZ6493A3 (de) |
| DE (2) | DE122006000065I2 (de) |
| DK (1) | DK0540609T3 (de) |
| ES (1) | ES2137162T3 (de) |
| FI (1) | FI930270L (de) |
| GR (1) | GR3031711T3 (de) |
| HU (1) | HUT63628A (de) |
| IE (1) | IE912569A1 (de) |
| IL (1) | IL98909A0 (de) |
| LU (1) | LU91290I2 (de) |
| MX (1) | MX9100317A (de) |
| MY (1) | MY106399A (de) |
| NL (1) | NL300249I2 (de) |
| NO (1) | NO930226L (de) |
| NZ (1) | NZ239061A (de) |
| PT (1) | PT98426A (de) |
| WO (2) | WO1992001696A1 (de) |
| YU (1) | YU129691A (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9125645D0 (en) * | 1991-12-03 | 1992-01-29 | Smithkline Beecham Plc | Novel compounds |
| JPH07503460A (ja) * | 1992-01-22 | 1995-04-13 | ファイザー・インコーポレイテッド | 2−イソセフェムおよびオキサセファム誘導体,それらの製法,その中間体および抗菌剤としての使用 |
| GB9212609D0 (en) * | 1992-06-13 | 1992-07-29 | Smithkline Beecham Plc | Novel compounds |
| GB9213567D0 (en) * | 1992-06-26 | 1992-08-12 | Smithkline Beecham Plc | Novel compounds |
| GB9424847D0 (en) * | 1994-12-09 | 1995-02-08 | Smithkline Beecham Plc | Novel process |
| GB2300856A (en) * | 1995-05-16 | 1996-11-20 | Pfizer Ltd | Beta-lactam preparation |
| WO1998014421A1 (en) * | 1996-10-02 | 1998-04-09 | Daiichi Pharmaceutical Co., Ltd. | Method for esterifying carboxylic compounds |
| FR2776292B1 (fr) | 1998-03-20 | 2004-09-10 | Oncopharm | Cephalotaxanes porteurs de chaine laterale et leur procede de synthese |
| GB0019124D0 (en) | 2000-08-03 | 2000-09-27 | Pfizer | Novel process |
| EP1339723B1 (de) * | 2000-12-04 | 2006-03-08 | Pfizer Products Inc. | Verfahren und esterderivate zur herstellung von cephalosphorinen |
| IL155714A0 (en) * | 2000-12-04 | 2003-11-23 | Pfizer Prod Inc | Coupling process and intermediates useful for preparing cephalosphorins |
| US7378408B2 (en) * | 2001-11-30 | 2008-05-27 | Pfizer Inc. | Methods of treatment and formulations of cephalosporin |
| KR100710555B1 (ko) | 2001-12-04 | 2007-04-24 | 에스케이 주식회사 | 광학적으로 순수한 (r)-폼 또는 (s)-폼의테트라히드로퓨라닐 케톤의 제조방법 |
| SG10201913554YA (en) | 2011-12-22 | 2020-03-30 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| MX2014014323A (es) | 2012-05-25 | 2015-02-12 | Janssen R & D Ireland | Nucleosidos de espirooxetano de uracilo. |
| BR112015014457A2 (pt) | 2012-12-21 | 2017-11-21 | Alios Biopharma Inc | composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c |
| CN105254648B (zh) * | 2015-11-13 | 2018-04-03 | 广东温氏大华农生物科技有限公司 | 一种头孢维星及其钠盐的合成方法 |
| GB2575261B (en) | 2018-07-02 | 2022-03-09 | Norbrook Lab Ltd | Intermediates in the synthesis of C3-substituted cephalosporins |
| JP2021534196A (ja) | 2018-08-23 | 2021-12-09 | シージェン インコーポレイテッド | 抗tigit抗体 |
| BR112022010924A2 (pt) | 2019-12-06 | 2022-09-06 | Vertex Pharma | Tetra-hidrofuranos substituídos como moduladores de canais de sódio |
| TWI775313B (zh) | 2020-02-18 | 2022-08-21 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| KR20250133471A (ko) | 2020-02-18 | 2025-09-05 | 길리애드 사이언시즈, 인코포레이티드 | 항바이러스 화합물 |
| TWI883391B (zh) | 2020-02-18 | 2025-05-11 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| CN111620893B (zh) * | 2020-06-08 | 2021-12-14 | 重庆医药高等专科学校 | C-3位四氢呋喃取代的头孢菌素-铁载体耦合物及其制备方法和应用 |
| CA3216162A1 (en) | 2021-04-16 | 2022-10-20 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
| SMT202500481T1 (it) | 2021-06-04 | 2026-01-12 | Vertex Pharma | N-(idrossialchil(etero)aril)tetraidrofuran carbossammidi come modulatori di canali del sodio |
| AU2022328698B2 (en) | 2021-08-18 | 2025-02-20 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
| CN121181574B (zh) * | 2025-11-24 | 2026-02-24 | 重庆汉佩生物科技有限公司 | 一种头孢维星衍生物和应用以及制备方法 |
| CN121181573B (zh) * | 2025-11-24 | 2026-02-27 | 重庆汉佩生物科技有限公司 | 一种含c-3位四氢呋喃头孢菌素衍生物和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2197573A1 (en) * | 1972-09-07 | 1974-03-29 | Roussel Uclaf | 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci |
| BE793448A (fr) * | 1971-12-31 | 1973-06-28 | Roussel Uclaf | Procede de preparation de nouveaux derives des cephalosporines et produits obtenus |
| BE791160A (fr) * | 1972-01-03 | 1973-05-09 | Beecham Group Ltd | Nouveaux cephemes substitues |
| BE791161A (fr) * | 1972-01-03 | 1973-05-09 | Beecham Group Ltd | Procede pour la preparation d'analogues des cephalosporines |
| NL7305936A (de) * | 1972-05-05 | 1973-11-07 | ||
| JPS5849382A (ja) * | 1981-09-18 | 1983-03-23 | Kyowa Hakko Kogyo Co Ltd | β−ラクタム化合物 |
| GB8821797D0 (en) * | 1988-09-16 | 1988-10-19 | Beecham Group Plc | Novel compounds |
| DK0395219T3 (da) * | 1989-03-30 | 1999-02-15 | Pfizer | Cephalosporiner og deres homologer, fremgangsmåde til deres fremstilling og farmaceutiske præparater |
-
1991
- 1991-07-16 MY MYPI91001321A patent/MY106399A/en unknown
- 1991-07-22 WO PCT/GB1991/001228 patent/WO1992001696A1/en not_active Ceased
- 1991-07-22 AP APAP/P/1991/000305A patent/AP832A/en active
- 1991-07-22 IL IL98909A patent/IL98909A0/xx unknown
- 1991-07-22 JP JP3512368A patent/JP2851428B2/ja not_active Expired - Lifetime
- 1991-07-22 WO PCT/GB1991/001227 patent/WO1992001695A1/en not_active Ceased
- 1991-07-22 DE DE200612000065 patent/DE122006000065I2/de active Active
- 1991-07-22 CA CA002359744A patent/CA2359744C/en not_active Expired - Lifetime
- 1991-07-22 HU HU93177A patent/HUT63628A/hu unknown
- 1991-07-22 DK DK91913583T patent/DK0540609T3/da active
- 1991-07-22 EP EP91913583A patent/EP0540609B1/de not_active Expired - Lifetime
- 1991-07-22 DE DE69131714T patent/DE69131714T2/de not_active Expired - Lifetime
- 1991-07-22 IE IE256991A patent/IE912569A1/en not_active IP Right Cessation
- 1991-07-22 MX MX9100317A patent/MX9100317A/es unknown
- 1991-07-22 AT AT91913583T patent/ATE185567T1/de active
- 1991-07-22 KR KR1019930700216A patent/KR100189075B1/ko not_active Expired - Lifetime
- 1991-07-22 ES ES91913583T patent/ES2137162T3/es not_active Expired - Lifetime
- 1991-07-22 JP JP3512255A patent/JPH05509089A/ja active Pending
- 1991-07-22 NZ NZ239061A patent/NZ239061A/en not_active IP Right Cessation
- 1991-07-22 CZ CS9364A patent/CZ6493A3/cs unknown
- 1991-07-22 FI FI930270A patent/FI930270L/fi unknown
- 1991-07-22 EP EP91913545A patent/EP0540606A1/de not_active Withdrawn
- 1991-07-22 AU AU82224/91A patent/AU648329B2/en not_active Expired
- 1991-07-22 CA CA002087967A patent/CA2087967C/en not_active Expired - Lifetime
- 1991-07-23 YU YU129691A patent/YU129691A/sh unknown
- 1991-07-23 PT PT98426A patent/PT98426A/pt not_active Application Discontinuation
- 1991-07-24 CN CN91105783A patent/CN1061046C/zh not_active Expired - Lifetime
-
1993
- 1993-01-22 NO NO93930226A patent/NO930226L/no unknown
-
1998
- 1998-11-14 CN CN98122407A patent/CN1111410C/zh not_active Expired - Lifetime
-
1999
- 1999-11-03 GR GR990402803T patent/GR3031711T3/el unknown
-
2006
- 2006-11-22 LU LU91290C patent/LU91290I2/fr unknown
- 2006-11-27 NL NL300249C patent/NL300249I2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE185567T1 (de) | Cephalosporine und ihre homologen, zubereitungen und pharmazeutsiche präparate | |
| FI924340L (fi) | Farmaceutiska beredningar | |
| FI911986L (fi) | Farmaceutiska foereningar. | |
| FI915826L (fi) | Farmaceutiska aemnen. | |
| FI914607L (fi) | Farmaceutisk blandning i gelform i en dispenserfoerpackning. | |
| FI930882A7 (fi) | Farmaceutiska foereningar | |
| NO922005D0 (no) | Farmasoeytiske preparater | |
| NO965539D0 (no) | Farmasöytiske tacrinepreparater | |
| FI894611A7 (fi) | Rakeisia farmaseuttisia valmisteita | |
| FI932445L (fi) | Farmaceutiska foereningar | |
| FI964285L (fi) | Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet | |
| FI924551A7 (fi) | Farmaceutiska foereningar | |
| FI935065L (fi) | Farmaceutiska foereningar | |
| FI931251L (fi) | Farmaceutiska foereningar | |
| FI930719A7 (fi) | Farmaceutiska foereningar | |
| KR930703307A (ko) | 제약품 | |
| FI921877L (fi) | Farmaceutiska foereningar | |
| FI910580L (fi) | Partikelformigt medel. | |
| FI934317A0 (fi) | Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen | |
| HRP950267A2 (en) | Heterocyclic compounds, pharmaceutical preparations containing them and the preparation thereof | |
| KR920007598U (ko) | 의약용 캅셀 | |
| ZA915725B (en) | Cephalosporins and homologues,preparations and pharmaceutical compositions | |
| NO920039L (no) | Farmasoeytiske preparater | |
| SE9302429D0 (sv) | New pharmaceutical preparation ii | |
| DK204190D0 (da) | Farmaceutisk praeparat |